Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
about
Single-neuron and genetic correlates of autistic behavior in macaque.From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismAn association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophreniaAntioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophreniaDecreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study.Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry.Novel implications of Lingo-1 and its signaling partners in schizophreniaA cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depressionHarnessing the power of yeast to elucidate the role of sphingolipids in metabolic and signaling processes pertinent to psychiatric disorders.Extracellular matrix abnormalities in schizophreniaAltered fatty acid concentrations in prefrontal cortex of schizophrenic patients.Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?Evidence for disruption of sphingolipid metabolism in schizophrenia.First experimental evidence of dopamine interactions with negatively charged model biomembranesPhospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia.Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia.Understanding aberrant white matter development in schizophrenia: an avenue for therapy?Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies.Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders.Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations.Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes.Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia.Altered 13C glucose metabolism in the cortico-striato-thalamo-cortical loop in the MK-801 rat model of schizophreniaBrain banking: opportunities, challenges and meaning for the future.Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls.Proteomics as a tool for understanding schizophrenia.Simultaneous lipidomic and transcriptomic profiling in mouse brain punches of acute epileptic seizure model compared to controls.A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient.Altered brain lipid composition in cyclooxygenase-2 knockout mouse.Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans.Strong preferences of dopamine and l-dopa towards lipid head group: importance of lipid composition and implication for neurotransmitter metabolism
P2860
Q27333227-F413098F-8FB2-4634-AF59-5772C8A3777FQ28067617-8C0732C1-B2F8-499C-8681-80428174C5D7Q28250481-088D558F-27E1-4F17-8969-5E12D7689DCFQ33350202-C59C23FE-5564-4EF2-B6F6-08DCE3B1C243Q33629435-6C48EA01-BB81-46FD-9F54-CEFEC5368EC8Q33715071-698E20A9-5836-47D9-9B60-214666D377C7Q33861618-5617AE3A-0CDB-4ABE-A42D-E590C6C7E5A9Q34399243-055FD7ED-6CF9-4FFF-A891-7D5B300F814DQ35014891-14FB34D8-946F-4319-A914-11E05419431DQ35149929-9E1A16AA-9ED5-44B0-8C23-5EFE8E76CDA7Q35603175-B2C0133F-A24C-4B3F-B544-59C9B19B9C1AQ36750552-262EE488-AE4A-4814-9149-8D921AF5B02CQ36814158-0603B860-8985-4AB8-A06D-13BBC3E1977EQ37023186-699D7D54-1DCA-4CFE-8D8D-E39EC427B3D8Q37025882-D2F50942-EE0C-4322-96DB-58DBA0090CFBQ37029108-02AA607C-2CEF-4A3E-A9E6-43055EEA969BQ37130617-CA9DBC72-230B-49ED-95DF-58B42FAD28B2Q37763856-B2B46F1C-8988-48ED-B222-9A1933DFCC99Q37896626-523CF7D5-CE76-4A51-9442-CEFA0D291CA6Q38323472-63741477-933A-4E2B-A78E-719534631DAAQ38607507-DBDEA34B-D56B-46DA-AC1A-2E74B1F0200BQ38629703-ED5B5BEF-A768-496B-A8DA-DAB277CE7C1FQ38764689-4B2BC173-17E6-4D2F-985A-80C4C2E53A4DQ38805367-0F0D0D8D-F571-4F73-8E42-F55F3965C26FQ39324465-ABE4D11C-A25D-4564-8330-D82B8ADCFE55Q39488903-0990836F-FCB9-4824-B689-FBD1BB1F6B80Q42108290-69E68CF8-E894-462A-ADA9-7966F7760271Q42200896-877D81EF-BB50-474D-8AD9-42C4C3024395Q42604971-8CA056C5-05FF-462C-973A-338D0C1BD431Q43072099-4DB480D2-C85B-4EFE-B1FE-2529E1DCC391Q43235632-5BAFAF09-4B03-4CA9-80A2-9CF4756AC6D7Q47363203-423AD870-9C21-46BF-8A9E-584DCEC110F6Q47557959-E508A39F-E5F5-42B5-8232-3A2DB4CCC4AAQ48320119-6695FA64-DC99-4BF0-A3E7-728F4FE0C43EQ50481966-B16A8C3F-A599-4F5D-83F0-02B442633334Q57889099-4E8A973B-3048-40CA-B92A-F6D2EF62617B
P2860
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
@en
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
@nl
type
label
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
@en
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
@nl
prefLabel
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
@en
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
@nl
P2093
P1476
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
@en
P2093
Alexander Jatzko
Athanasios Maras
Dieter F Braus
Georg Petroianu
Katrin Wilczek
Wagner F Gattaz
P356
10.1016/J.BIOPSYCH.2004.03.019
P407
P577
2004-07-01T00:00:00Z